Why an Investor Letter Put Plexus (PLXS) Back on Investors’ Radar

Recent commentary in Riverwater Partners’ Q1 2026 investor letter has put Plexus (PLXS) in focus, highlighting activity related to semiconductor equipment demand, new robotics wins, and fresh healthcare orders.

Plexus shares have moved sharply higher in recent months, with a 43.6% 90 day share price return and 99.3% 1 year total shareholder return. This suggests momentum has been building as investors react to semiconductor, robotics, and healthcare order wins.

If Plexus’s recent run has caught your attention, it could be a useful moment to see what else is moving in electronics manufacturing and automation through 35 robotics and automation stocks

With the shares at $249.87, above the US$210.80 analyst price target and a 1-year total return of 99.3%, investors may question whether Plexus is now fully valued or if markets are still underestimating its prospects.

Most Popular Narrative: 24.4% Overvalued

With Plexus shares at $249.87 against a narrative fair value of $200.80, the current price sits well above what this model implies, putting the focus squarely on how the company uses its capital and growth options.

Robust free cash flow generation and improved working capital efficiency have enabled greater returns to shareholders and provide Plexus with flexibility for further growth investments, supporting long-term earnings expansion.

Curious what kind of revenue mix, margin profile, and earnings path need to line up for this valuation to make sense? The narrative leans on specific growth assumptions, a defined profit trajectory, and a future earnings multiple that together have a tight margin for error.

Result: Fair Value of $200.80 (OVERVALUED)

However, tariff uncertainty and customer concentration still matter, as order delays or reduced volumes from a few large clients could quickly challenge the earnings path built into current expectations.

Next Steps

The mix of optimism and concern around Plexus is clear, so it makes sense to review the numbers yourself and decide how you feel about the balance between potential upside and downside drivers, starting with 2 key rewards and 1 important warning sign.

Looking for more investment ideas?

If Plexus has you thinking more broadly about your portfolio, now is a good time to line up a few fresh ideas that match how you like to invest.

• Target quality at a discount by scanning a focused set of 54 high quality undervalued stocks that pair robust fundamentals with prices below their implied worth.
• Prioritise resilience by reviewing 74 resilient stocks with low risk scores that score well on stability, volatility, and balance sheet strength.
• Spot potential early movers by checking a screener containing 23 high quality undiscovered gems that the wider market may not be paying attention to yet.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.